S
Sami Kolta
Researcher at Paris Descartes University
Publications - 89
Citations - 3690
Sami Kolta is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 31, co-authored 87 publications receiving 3460 citations. Previous affiliations of Sami Kolta include University of Paris & Pierre-and-Marie-Curie University.
Papers
More filters
Journal ArticleDOI
Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study.
Claus C. Glüer,Richard Eastell,David M. Reid,Dieter Felsenberg,Christian Roux,Reinhard Barkmann,Wolfram Timm,Tilo Blenk,Gabi Armbrecht,Alison Stewart,Jackie A. Clowes,F. Thomasius,Sami Kolta +12 more
TL;DR: QUS of the calcaneus performed as well as central DXA in a population‐based sample of 2837 women with and without osteoporotic vertebral fractures.
Journal ArticleDOI
Metabolic bone assessment in patients with inflammatory bowel disease
Vered Abitbol,Christian Roux,Stanislas Chaussade,Serge Guillemant,Sami Kolta,Maxime Dougados,Daniel Couturier,Bernard Amor +7 more
TL;DR: The results suggest that bone turnover in inflammatory bowel disease is characterized by low bone formation in the presence of normal levels of calcium-regulating hormones.
Journal ArticleDOI
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
Claudine Duvivier,Sami Kolta,Lambert Assoumou,Lambert Assoumou,Jade Ghosn,Sylvie Rozenberg,Robert L. Murphy,Christine Katlama,Christine Katlama,Christine Katlama,Dominique Costagliola,Dominique Costagliola,Dominique Costagliola +12 more
TL;DR: BMD was impaired in 34% of patients, before starting any antiretrovirals, and after 1 year, the decrease in lumbar spine BMD was more pronounced in patients receiving either PI/r-containing regimen compared with NNRTI and NRTIs.
Journal ArticleDOI
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
Karine Briot,Bernard Cortet,Thierry Thomas,Maurice Audran,Hubert Blain,Véronique Breuil,Laure Chapuis,Roland Chapurlat,Patrice Fardellone,Jean-Marc Feron,Jean-Bernard Gauvain,Pascal Guggenbuhl,Sami Kolta,Eric Lespessailles,Brigitte Letombe,Christian Marcelli,Philippe Orcel,Patrick Seret,Florence Trémollières,Christian Roux +19 more
TL;DR: The updated recommendations underline the need for osteoporosis pharmacotherapy in women with a history of severe osteOPorotic fracture and provide clinicians with clarifications about the pharmacological treatment of osteoporeosis.
Journal ArticleDOI
Mild prevalent and incident vertebral fractures are risk factors for new fractures
TL;DR: Mild vertebral fractures are a risk factor for subsequent vertebral and non-vertebral fracture in postmenopausal women with osteoporosis; 1 out of 4 patients with an incident mild vertebra fracture in 2 years will fracture again within the 2 next years.